Walmart (WMT) is looking to own the last mile of the GLP-1 sales boom by launching a platform that goes beyond prescriptions to combine virtual care and nutrition, according to Axios. The retail giant ...

NIH researchers have identified the intracellular signalling pathways through which semaglutide and other GLP-1 receptor agonists induce weight loss, revealing why patient responses vary and treatment ...

Some patients taking GLP-1 drugs to lose weight or manage Type 2 diabetes are discovering an emerging potential side effect ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ...

One of the biggest stories in the food and restaurant sector has been the growing popularity and acceptance of GLP-1 weight-loss drugs. The main concern if you are in the business of selling pizzas is ...

The latest report from Morgan Stanley on GLP-1 adoption in the U.S. indicates that usage is accelerating, with oral formulations and expanded access expected to unlock a broader user base over the ...

GLP-1 drugs have dominated the food and beverage conversation for the past two years. They’ve reignited an industry-wide fixation on weight loss as body positivity wanes, driven waves of new product ...

Ozempic has become so embedded in global culture that “Ozempic face” was shortlisted for a prominent dictionary’s word of the year in 2025. Ozempic isn’t the only drug that mimics the natural GLP-1 ...